Moraru Andreea Dana, Costin Dănuț, Moraru Radu Lucian, Costuleanu Marcel, Brănișteanu Daniel Constantin
Department of Ophthalmology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iaşi, Romania.
Department of Ophthalmology, 'Prof. N. Oblu' Clinical Hospital, 700309 Iași, Romania.
Exp Ther Med. 2020 Oct;20(4):3528-3535. doi: 10.3892/etm.2020.9094. Epub 2020 Aug 4.
This review presents a systematic analysis of the literature regarding the pachychoroid disease spectrum nomenclature, diagnosis criteria and therapeutic options. Pachychoroid related diseases are a new concept, introduced into the ophthalmological nomenclature in 2013 and evolving both as concept and as classification since then. The six disorders included in this phenotype have some common characteristics (thick choroid, pachyvessels, attenuation of the choriocapillaris), but also show individual features. The classification of the pachychoroid spectrum was revised many times, with the recent addition of the focal choroidal excavation (FCE) and peripapillary pachychoroid syndrome (PPS). As the terminology is developing, so is the number of case reports and case series from the initial report in 2013 to 57 reports in 2019. This review takes into account both the current literature and the clinical experience of the authors, emphasizing the understanding of the pathogenesis and aiming to update the therapeutic options available.
本综述对关于肥厚性脉络膜疾病谱命名、诊断标准和治疗选择的文献进行了系统分析。肥厚性脉络膜相关疾病是一个新概念,于2013年被引入眼科命名法,从那时起,其作为一个概念和分类都在不断发展。该表型所包含的六种疾病有一些共同特征(脉络膜增厚、血管增厚、脉络膜毛细血管变薄),但也呈现出各自的特点。肥厚性脉络膜疾病谱的分类多次修订,最近增加了局灶性脉络膜凹陷(FCE)和视乳头周围肥厚性脉络膜综合征(PPS)。随着术语的不断发展,病例报告和病例系列的数量也在增加,从2013年的首次报告到2019年的57份报告。本综述兼顾了当前的文献和作者的临床经验,强调对发病机制的理解,并旨在更新现有的治疗选择。